Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen Completed Phase 3 Trials for Meningococcal Meningitis / Meningococcal Infections / Meningitis Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT02842853Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine
NCT01890759Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation
NCT01086969A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India
NCT01359449Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations
NCT01519713Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects
NCT00616421Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children